Reduction of albumin excretion rate in normotensive micrealbuminuric type 2 diabetic patients during long-term simvastatin treatment

Diabetes Care

Volumn 20, Issue 12, 1997, Pages 1891-1895

  Tonolo, Giancarlo ^a   Ciccarese, Milco ^a   Brizzi, Patrizia ^a   Puddu, Loreta ^a   Secchi, Giannina ^a   Calvia, Pierangela ^a   Atzeni, Maria M ^a   Melis, Maria G ^a   Maioli, Mario ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EXCRETION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY FUNCTION; MALE; MESANGIUM CELL; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; URINARY EXCRETION;

EID: 0030827539     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.12.1891     Document Type: Article

References (32)

1. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes mellitus. N Engl J Med 310:356-360, 1984
2. Castelli WP: The epidemiology of coronary heart disease: the Framingham Study. Am Heart J 27:4-12, 1984
3. Multiple Risk Factor Intervention Trial Research Group: Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 248:1465-1472, 1982
4. Diamond JR, Karnovsky MJ: Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 33:917-924, 1988
5. Diamond JR, Karnovsky MJ: Exacerbation of chronic amino nucleoside nephrosis by dietary cholesterol supplementation. Kidney Int 32:671-677, 1987
6. Kasiske BL, O'Donnell MP, Garvis WJ, Keane WF: Pharmacological treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res 62:367-374, 1988
7. O'Donnell MP, Kasiske BL, Katz SA, Schmitz PG, Keane WF: Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats. Hypertension 20:651-658, 1992
8. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF: Treatment of hyperlipidaemia reduces glomerular injury in obese Zucker rats. Kidney Int 33:667-672, 1988
9. Goldstein DJ, Wheeler DC, Sandstrom DJ, Kawachi H, Salant DJ: Fish oil ameliorates renal injury and hyperlipidemia in the Milan normotensive rat model of focal glomerulosclerosis. J Am Soc Nephrol 6: 1468-1475, 1995
10. Diamond JR, Kamovsky MJ: A putative role of hypercholesterolemia in progressive glomerular injury Ann Rev Med 43:83-92, 1992
11. Grandaliano G, Biswas P, Choudhury GG, Abboud HE: Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells. Kidney Int 44:503-508, 1983
12. O'Donnel MP, Kasiske BL, Kim Y, Atluru D, Keano WF: Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest 91:83-87, 1993
13. Maioli M, Boschi F, Pettinato S, Area GM, Cherchi GM, Pacifico A, Uras F, Realdi G: Electrocardiographic changes indicative of coronary heart disease in beta-thalassemia trait carriers: comparison with normal subjects. Giornale dell'Arteriosclerosi 15:133-139,1990
14. Maioli M, Tonolo G, Pacifico A, Ciccarese M, Brizzi P, Kohner EM, Porta M: Raised serum apolipoprotein (a) in active diabetic retinopathy Diabetologia 36:88-90, 1993
15. Friedewald WT, Levy RI, Fredrickson S: Estimate of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-504, 1972
16. Mattock M: Microalbuminuria as a predictor of mortality in type 2 diabetic patients: results of a three years prospective study (Abstract). Diabetologia 33:49a, 1990
17. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as a predictor of vascular disease in nondiabetic subjects. Lancet ii:530-533, 1988
18. Mogensen CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31:673-689, 1987
19. Moorhead JF, Chan MK, El-Nabes M, Varguez Z: Lipid nephrotoxicity in chronic progressive glomerular and tubules interstitial disease. Lancet ii:1309-1311, 1982
20. Takemura T, Yoshioka K, Aya N, Murakami K, Matsumoto A, Itakura H: Apolipoproteins and lipoprotein receptor in glomeruli in human kidney disease. Kidney Int 43:918-927, 1993
21. Camejo G, Lopez A, Lopez F, Quinones J: Interaction of low-density lipoproteins with arterial proteoglycans: the role of charge and sialic acid content. Atherosclerosis 55:93-105, 1985
22. Coini R, Cherchi G, Formato M, Demuro P, De Luca G: LDL interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement. Haematologica 78:270-276, 1993
23. Rabelink AJ, Hene RJ, Erkelens, DW, Joleds JA, Koomans HA: Partial remission of nephrotic syndrome in patients on long-term simvastatin. Lancet 335:1045-1046, 1990
24. Lam KSL, Cheng IKP, Janus ED, Pang RWC: Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38:604-609, 1995
25. Nielsen S, Schmitz O, Moller N, Porksen N, Klausen IC, Alberti KGMM, Mogensen CE: Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 36:1079-1086, 1993
26. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM: Glomerular lesions and urinary albumin excretion in type 1 diabetes without overt proteinuria. N Engl J Med 320:966-970, 1989
27. Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioli M, Carraro A, Tonolo G, Fresu P, Cernigoi AM, Fioretto P, Nosadini R: Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 45:216-222, 1996
28. Lopes-Virella MF, Woltmann HT, Mayfield RK, Loadholt GB, Colwell JA: Effects of metabolic control on lipid lipoprotein levels in 55 insulin-dependent patients: a longitudinal study. Diabetes 32:20-25, 1983
29. Viberti GC, Pickup JC, Janet RJ, Keen H: Effect of control of blood glucose on urinary excretion of albumin and β2-microglobulin in insulin-dependent diabetes. N Engl J Med 300:638-641, 1979
30. Oliver MF, Boyd GS: Changes in the plasma lipids during the menstrual cycle. Clin Sci 12:217-220, 1953
31. Tonolo G, Ciccarese M, Brizzi P, Milia S, Dessole S, Puddu L, Secchi G, Maioli M: Cyclical variation of plasma lipids, apolipoproteins and lipoprotein(a) during the menstrual cycle in normal women. Am J Physiol 269:E1101-E1105, 1995
32. Willey KA, Kidd JF, Harris JP, Xu ZR, Yue DK: Albuminuria is an independent predictor of carotid intima-media thickness and atherosclerosis in NIDDM patients. Diabetes Care 18:1502-1503, 1995